Hormone Therapy in Trauma Patients

Crit Care Clin. 2019 Apr;35(2):201-211. doi: 10.1016/j.ccc.2018.11.009. Epub 2019 Jan 24.

Abstract

Low-dose hydrocortisone reduces the dose of vasopressors and hospital length of stay; it may also decrease the rate of hospital-acquired pneumonia and time on ventilator. No major side effect was reported, but glycemia and natremia should be monitored. Progesterone did not enhance outcome of trauma patients. A meta-analysis suggested that oxandrolone was associated with shorter length of stay and reduced weight loss. Erythropoietin did not enhance neurologic outcome of traumatic brain-injured patients; such treatment, however, could reduce the mortality in subgroups of patients. This review focuses mainly on glucocorticoids, which are the most extensively investigated treatments in hormone therapy.

Keywords: Corticosteroids; Critical illness; Erythropoietin; Low-dose hydrocortisone; Progesterone; Trauma patients; Traumatic brain injury.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Erythropoietin / therapeutic use*
  • Female
  • Hormones / therapeutic use*
  • Humans
  • Hydrocortisone / therapeutic use*
  • Length of Stay / statistics & numerical data*
  • Male
  • Oxandrolone / therapeutic use*
  • Progesterone / therapeutic use*
  • Wounds and Injuries / drug therapy*

Substances

  • Hormones
  • Erythropoietin
  • Progesterone
  • Oxandrolone
  • Hydrocortisone